Mark For: VELOX™ trademark registration is intended to cover the categories of pharmaceutical preparations for T Cell therapy; pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer autoimmune diseases, and immunological disorders; chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposes, for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders.
Status
2021-01-26 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Brendan J. Hughes
Attorney Docket Number
310410-20000
Timeline
2021-01-22
Application Filed
2021-01-26
Location: NEW APPLICATION PROCESSING
2021-01-26
Status: Live/Pending
2021-01-26
Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
BRENDAN J. HUGHES COOLEY LLP 1299 PENNSYLVANIA AVENUE NW, SUITE 700 WASHINGTON, DC 20004-2400
Good, Services, and Codes
International Codes:
5
U.S. Codes:
005,006,018,044,046,051,052
International Codes:
40
U.S. Codes:
100,103,106
International Codes:
44
U.S. Codes:
100,101
Type Code
Type
GS0051
Pharmaceutical preparations for T Cell therapy; pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer autoimmune diseases, and immunological disorders; chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposes, for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
OneLook
Acronym Finder
Velox Therapeutics, Inc.
Application
Drawing
| 